您的位置：首页 > 产品中心 > 113852-37-2， Cidofovir hydrate
Cidofovir hydrate
产品价格查看更多规格...
| 产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
| 3425912 | 10 MG | 1141 | |||
| 3425912 | 50 MG | 3150 |
产品别名
113852-37-2
Cidofovir hydrate
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine
(S)-HPMPC; Cidovir
HPMPC
Vistide
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C8H14N3O6P · xH2O |
| Molecular weight | 279.19 (anhydrous basis) |
| MDL number | MFCD17215968 |
| PubChem Substance ID【PubChem化学物质编号】 | 329775105 |
| NACRES | NA.77 |
| Biochem/physiol Actions【生化/生理作用】 | Selective inhibitor of viral DNA synthesis through the selective inhibition of viral DNA polymerase. |
| Features and Benefits【特点和优势】 | This compound was developed by Pfizer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm. |
产品性质
| Quality Level【质量水平】 | 100 |
| Assay【测定】 | ≥98% (HPLC) |
| form【形式】 | powder |
| storage condition【储存条件】 | desiccated protect from light |
| solubility【溶解性】 | deionized water: ≥5 mg/mL (warmed) |
| originator【创始人】 | Pfizer |
| storage temp.【储存温度】 | room temp |
| SMILES string | O.NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1 |
| InChI | 1S/C8H14N3O6P.H2O/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16;/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16);1H2/t6-;/m0./s1 |
| InChI key | KLJYJZIIJLYJNN-RGMNGODLSA-N |
| packaging【包装】 | 10, 50 mg in glass bottle |
安全信息
| Pictograms【象形图】 | GHS06 |
| Signal word【警示用语：】 | Danger |
| Hazard Statements | H301 - H315 |
| Precautionary Statements | P301 + P310 + P330 - P302 + P352 |
| Hazard Classifications【危险分类】 | Acute Tox. 3 Oral - Skin Irrit. 2 |
| Storage Class Code【储存分类代码】 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects |
| WGK | WGK 3 |
